Transparency - Ireland

In Europe, we are a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), and endorse the EFPIA Disclosure Code, a set of guiding principles that requires pharmaceutical companies to publicly disclose transfers of value made to European health care professionals and health care organizations.

EFPIA

Biogen strongly believes that collaboration with Healthcare Professionals and Healthcare Organisations is crucial to discover, develop and deliver innovative therapies that improve the lives of patients. At the same time, we believe that these interactions must be conducted openly and transparently.
 
As a member of EFPIA (the European Federation of Pharmaceutical Industries and Associations) and IPHA (the Irish Pharmaceutical Healthcare Association), Biogen is proud to endorse and uphold the EFPIA Disclosure Code and the IPHA Code of Practice disclosure requirements. In line with the codes, Biogen has been collecting all payments and contributions made to HCPs and HCOs since January 2015.

These payments are published on IPHA’s central report on their website.

 

 

 
BI-PAN-0404b(5)    Date of Preparation:  September 2018

Patient Organisation Support

Biogen is proud to work with Patient Organisations and support their efforts to improve the lives of their members and raise awareness of serious medical conditions. We are aligned in enhancing patient advocacy and supporting medical research for the discovery of effective therapies. Below is a breakdown of the support Biogen has provided to Patient Organisations in Ireland.

 

2017

In 2017 Biogen contributed €20,000.00 to Irish Patient Organisations

Name Purpose Amount of support
MS Ireland Project Funding Grant for MS Ireland 2017 €20,000

 

 
BI-PAN-0404b(5)    Date of Preparation:  September 2018